Category: Vaccines
Vaccines market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Human Papillomavirus Vaccines
The 2025-2030 World Outlook for Human Papillomavirus Vaccines This study covers the world outlook for human papillomavirus vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Human Influenza Vaccines
The 2025-2030 World Outlook for Human Influenza Vaccines This study covers the world outlook for human influenza vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Hepatitis B Vaccines
The 2025-2030 World Outlook for Hepatitis B Vaccines This study covers the world outlook for hepatitis b vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Clostridium Vaccines
The 2025-2030 World Outlook for Clostridium Vaccines This study covers the world outlook for clostridium vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Cholera Vaccines
The 2025-2030 World Outlook for Cholera Vaccines This study covers the world outlook for cholera vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Zika Virus Vaccines
The 2025-2030 World Outlook for Zika Virus Vaccines This study covers the world outlook for zika virus vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Subunit Animal Vaccines
The 2025-2030 World Outlook for Subunit Animal Vaccines This study covers the world outlook for subunit animal vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Potential Analysis of Human DNA Vaccines
The 2025-2030 World Outlook for Potential Analysis of Human DNA Vaccines This study covers the world outlook for potential analysis of human DNA vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for Human Vaccines
The 2025-2030 World Outlook for Human Vaccines This study covers the world outlook for human vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More
-
The 2025-2030 World Outlook for Live Vaccines
The 2025-2030 World Outlook for Live Vaccines This study covers the world outlook for live vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More
-
The 2025-2030 World Outlook for Paediatric Vaccines
The 2025-2030 World Outlook for Paediatric Vaccines This study covers the world outlook for paediatric vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Autogenous Vaccines
The 2025-2030 World Outlook for Autogenous Vaccines This study covers the world outlook for autogenous vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Veterinary and Animal Vaccines
The 2025-2030 World Outlook for Veterinary and Animal Vaccines This study covers the world outlook for veterinary and animal vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Polysaccharide Meningococcal Vaccines
The 2025-2030 World Outlook for Polysaccharide Meningococcal Vaccines This study covers the world outlook for polysaccharide meningococcal vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Porcine Vaccines
The 2025-2030 World Outlook for Porcine Vaccines This study covers the world outlook for porcine vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for DNA Animal Vaccines
The 2025-2030 World Outlook for DNA Animal Vaccines This study covers the world outlook for DNA animal vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Dengue Vaccine for Age Group >12 Years
The 2025-2030 World Outlook for Dengue Vaccine for Age Group >12 Years This study covers the world outlook for dengue vaccine for age group >12 years across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Pediatric Drugs and Vaccines
The 2025-2030 World Outlook for Pediatric Drugs and Vaccines This study covers the world outlook for pediatric drugs and vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for H1N1 2009 Influenza Vaccines
The 2025-2030 World Outlook for H1N1 2009 Influenza Vaccines This study covers the world outlook for H1N1 2009 influenza vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Vaccines Sales
The 2025-2030 World Outlook for Vaccines Sales This study covers the world outlook for vaccines sales across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More
-
The 2025-2030 World Outlook for Cancer Vaccines
The 2025-2030 World Outlook for Cancer Vaccines This study covers the world outlook for cancer vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Vaccine Contract Manufacturing
The 2025-2030 World Outlook for Vaccine Contract Manufacturing This study covers the world outlook for vaccine contract manufacturing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Conjugate Vaccines
The 2025-2030 World Outlook for Conjugate Vaccines This study covers the world outlook for conjugate vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for H1N1 Vaccines
The 2025-2030 World Outlook for H1N1 Vaccines This study covers the world outlook for H1N1 vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More
-
The 2025-2030 World Outlook for Vaccine Technologies
The 2025-2030 World Outlook for Vaccine Technologies This study covers the world outlook for vaccine technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
Research Assistance
